325 related articles for article (PubMed ID: 32023907)
1. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung JO; Nienhüser H; Schleussner N; Schmidt T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
[TBL] [Abstract][Full Text] [Related]
2. Oesophagogastric junction adenocarcinoma: which therapeutic approach?
Mariette C; Piessen G; Briez N; Gronnier C; Triboulet JP
Lancet Oncol; 2011 Mar; 12(3):296-305. PubMed ID: 21109491
[TBL] [Abstract][Full Text] [Related]
3. Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.
Brücher BL; Kitajima M; Siewert JR
Cancer Invest; 2014 Dec; 32(10):497-506. PubMed ID: 25250506
[TBL] [Abstract][Full Text] [Related]
4. [Role of postoperative chemoradiotherapy in the therapeutic management of adenocarcinomas of the stomach and oesogastric junction].
Ben Salah H; Bahri M; Dhouib F; Daoud J
Cancer Radiother; 2016 Dec; 20(8):830-832. PubMed ID: 27793531
[TBL] [Abstract][Full Text] [Related]
5. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
Catenacci DVT; Chase L; Lomnicki S; Karrison T; de Wilton Marsh R; Rampurwala MM; Narula S; Alpert L; Setia N; Xiao SY; Hart J; Siddiqui UD; Peterson B; Moore K; Kipping-Johnson K; Markevicius U; Gordon B; Allen K; Racette C; Maron SB; Liao CY; Polite BN; Kindler HL; Turaga K; Prachand VN; Roggin KK; Ferguson MK; Posner MC
JAMA Netw Open; 2020 Feb; 3(2):e1921290. PubMed ID: 32058557
[TBL] [Abstract][Full Text] [Related]
8. Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma.
Zhou KI; Hanks BA; Strickler JH
J Gastrointest Cancer; 2024 Jun; 55(2):483-496. PubMed ID: 38133871
[TBL] [Abstract][Full Text] [Related]
9. Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.
Maresch J; Schoppmann SF; Thallinger CM; Zielinski CC; Hejna M
Crit Rev Oncol Hematol; 2012 Jun; 82(3):310-22. PubMed ID: 21783379
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
Davidson M; Chau I
Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690
[TBL] [Abstract][Full Text] [Related]
12. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the Literature.
Kamposioras K; Ntellas P; Nikolaou M; Germetaki T; Gazouli I; Dadouli K; Zarkavelis G; Amylidi AL; Tolia M; Mauri D
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34926989
[TBL] [Abstract][Full Text] [Related]
14. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
Al-Batran SE; Lorenzen S
Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086
[TBL] [Abstract][Full Text] [Related]
15. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
Mönig SP; Berlth F; Chon SH
Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
[No Abstract] [Full Text] [Related]
16. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
17. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
[No Abstract] [Full Text] [Related]
18. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
Ajani JA; Correa AM; Swisher SG; Wu TT
J Clin Oncol; 2007 Sep; 25(27):4315-6. PubMed ID: 17878485
[No Abstract] [Full Text] [Related]
19. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Advances in the Treatment of Gastroesophageal Cancers.
Li JJ; Rogers JE; Yamashita K; Waters RE; Blum Murphy M; Ajani JA
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
